Neuronetics Inc

詳細情報 Neuronetics Inc 企業名

Neuronetics, Inc. is a medical technology company focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its NeuroStar Advanced Therapy for Mental Health is a non-drug, noninvasive treatment for people suffering from neurohealth conditions. In addition to selling the NeuroStar system and associated treatment sessions to customers, it operates treatment centers across the United States, offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or TMS) and Spravato (esketamine nasal spray) for the treatment of major depressive disorder (MDD) and other mental health disorders. NeuroStar Advanced Therapy is the TMS treatment for MDD in adults. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. It provides more than 1.68 million treatments to over 51,000 patients struggling with depression.

企業情報

企業コードSTIM

会社名Neuronetics Inc

上場日Jun 28, 2018

最高経営責任者「CEO」Mr. Keith J. Sullivan

従業員数716

証券種類Ordinary Share

決算期末Jun 28

本社所在地3222 Phoenixville Pike

都市MALVERN

証券取引所NASDAQ Global Market Consolidated

国United States of America

郵便番号19355

電話番号18776007555

ウェブサイトhttps://neurostar.com/neuronetics/

企業コードSTIM

上場日Jun 28, 2018

最高経営責任者「CEO」Mr. Keith J. Sullivan

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Sasha Cucuz

Director

2.02M

+1.50%

Mr. Keith J. Sullivan

President, Chief Executive Officer, Director

1.61M

--

Mr. Robert A. (Rob) Cascella

Independent Non-Executive Chairman of the Board

578.24K

+6.69%

Mr. Steven Pfanstiel

Chief Financial Officer, Executive Vice President, Treasurer

400.00K

--

Mr. Glenn P. Muir

Independent Director

327.90K

+10.07%

Ms. Sheryl L. Conley

Independent Director

178.03K

+20.27%

Ms. Megan Rosengarten

Independent Director

140.89K

+27.05%

Mr. W. Andrew Macan

Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary

--

Dr. Avinash N. Amin, M.D.

Director

--

Mr. Mark Klausner

Managing Partner

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Sasha Cucuz

Director

2.02M

+1.50%

Mr. Keith J. Sullivan

President, Chief Executive Officer, Director

1.61M

--

Mr. Robert A. (Rob) Cascella

Independent Non-Executive Chairman of the Board

578.24K

+6.69%

Mr. Steven Pfanstiel

Chief Financial Officer, Executive Vice President, Treasurer

400.00K

--

Mr. Glenn P. Muir

Independent Director

327.90K

+10.07%

Ms. Sheryl L. Conley

Independent Director

178.03K

+20.27%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Clinic revenue

18.66M

58.35%

Treatment sessions

9.76M

30.53%

NeuroStar Advanced Therapy System

3.01M

9.41%

Other

544.00K

1.70%

地域別USD

会社名

収益

比率

United States

31.48M

98.46%

International

492.00K

1.54%

事業別

地域別

事業別USD

会社名

収益

比率

Clinic revenue

18.66M

58.35%

Treatment sessions

9.76M

30.53%

NeuroStar Advanced Therapy System

3.01M

9.41%

Other

544.00K

1.70%

株主

更新時刻: Sat, Aug 23

株主統計

種類

株主統計

比率

Madryn Asset Management, LP

31.36%

The Vanguard Group, Inc.

4.15%

BlackRock Institutional Trust Company, N.A.

3.10%

Cucuz (Sasha)

3.06%

Sullivan (Keith J)

2.43%

他の

55.90%

株主統計

比率

Madryn Asset Management, LP

31.36%

The Vanguard Group, Inc.

4.15%

BlackRock Institutional Trust Company, N.A.

3.10%

Cucuz (Sasha)

3.06%

Sullivan (Keith J)

2.43%

他の

55.90%

種類

株主統計

比率

Private Equity

31.36%

Hedge Fund

10.96%

Investment Advisor

9.92%

Individual Investor

9.43%

Investment Advisor/Hedge Fund

4.84%

Research Firm

1.83%

Bank and Trust

0.10%

Pension Fund

0.07%

他の

31.49%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

187

47.56M

71.93%

-4.03M

2025Q1

191

47.19M

71.70%

-4.84M

2024Q4

155

36.70M

70.38%

+11.74M

2024Q3

153

14.58M

47.42%

-9.85M

2024Q2

159

20.22M

66.61%

-5.87M

2024Q1

183

20.38M

68.24%

-3.49M

2023Q4

191

18.37M

63.28%

-7.87M

2023Q3

201

19.69M

68.24%

-8.69M

2023Q2

222

21.10M

73.37%

-11.20M

2023Q1

226

22.33M

78.62%

-9.89M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Madryn Asset Management, LP

24.24M

36.82%

--

Mar 24, 2025

The Vanguard Group, Inc.

2.31M

3.5%

+1.02M

+79.97%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

378.86K

0.58%

-202.00

-0.05%

Mar 31, 2025

Cucuz (Sasha)

2.02M

3.08%

+30.00K

+1.50%

May 22, 2025

Sullivan (Keith J)

1.61M

2.44%

--

Mar 24, 2025

Balyasny Asset Management LP

1.42M

2.15%

-64.72K

-4.37%

Mar 31, 2025

Ikarian Capital LLC

1.10M

1.67%

+1.10M

--

Mar 31, 2025

Masters Capital Management, L.L.C.

1.00M

1.52%

-500.00K

-33.33%

Mar 31, 2025

Manatuck Hill Partners, LLC

920.00K

1.4%

+920.00K

--

Mar 31, 2025

詳細を見る

2.910USD

Neuronetics Inc

2.910

概要

企業名

金融

分析